BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 22925902)

  • 1. Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application.
    Nogueira da Costa A; Herceg Z
    Mol Oncol; 2012 Dec; 6(6):704-15. PubMed ID: 22925902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Epigenetic Markers for Precision Medicine.
    Dumitrescu RG
    Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic biomarkers in the blood of patients with urological malignancies.
    Ellinger J; Müller SC; Dietrich D
    Expert Rev Mol Diagn; 2015 Apr; 15(4):505-16. PubMed ID: 25719388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA.
    van der Pol Y; Mouliere F
    Cancer Cell; 2019 Oct; 36(4):350-368. PubMed ID: 31614115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Power of DNA Methylation Classifiers for Early Detection of Cancer.
    Roy D; Tiirikainen M
    Trends Cancer; 2020 Feb; 6(2):78-81. PubMed ID: 32061307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue and Cell-Free DNA-Based Epigenomic Approaches for Cancer Detection.
    Leal A; Sidransky D; Brait M
    Clin Chem; 2020 Jan; 66(1):105-116. PubMed ID: 31843869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics and Precision Oncology.
    Werner RJ; Kelly AD; Issa JJ
    Cancer J; 2017; 23(5):262-269. PubMed ID: 28926426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic biomarkers in aging and longevity: Current and future application.
    Izadi M; Sadri N; Abdi A; Serajian S; Jalalei D; Tahmasebi S
    Life Sci; 2024 Aug; 351():122842. PubMed ID: 38879158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic diagnostics of cancer--the application of DNA methylation markers.
    Paluszczak J; Baer-Dubowska W
    J Appl Genet; 2006; 47(4):365-75. PubMed ID: 17132902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic epigenetic biomarkers in cancer.
    Costa-Pinheiro P; Montezuma D; Henrique R; Jerónimo C
    Epigenomics; 2015; 7(6):1003-15. PubMed ID: 26479312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide epigenomic profiling for biomarker discovery.
    Dirks RA; Stunnenberg HG; Marks H
    Clin Epigenetics; 2016; 8():122. PubMed ID: 27895806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007.
    Lambert MP; Herceg Z
    Mol Oncol; 2008 Jun; 2(1):33-40. PubMed ID: 19383327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causes, effects, and clinical implications of perturbed patterns within the cancer epigenome.
    Oleksiewicz U; Machnik M
    Semin Cancer Biol; 2022 Aug; 83():15-35. PubMed ID: 33359485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer.
    Marzese DM; Hoon DS
    Expert Rev Mol Diagn; 2015 May; 15(5):647-64. PubMed ID: 25797072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer.
    Grady WM; Yu M; Markowitz SD
    Gastroenterology; 2021 Feb; 160(3):690-709. PubMed ID: 33279516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for cancer epigenome analysis.
    Nagarajan RP; Fouse SD; Bell RJ; Costello JF
    Adv Exp Med Biol; 2013; 754():313-38. PubMed ID: 22956508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyzing DNA Methylation Patterns During Tumor Evolution.
    Pan H; Elemento O
    Methods Mol Biol; 2018; 1711():27-53. PubMed ID: 29344884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and development of DNA methylation-based biomarkers for lung cancer.
    Walter K; Holcomb T; Januario T; Yauch RL; Du P; Bourgon R; Seshagiri S; Amler LC; Hampton GM; S Shames D
    Epigenomics; 2014 Feb; 6(1):59-72. PubMed ID: 24579947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenomics in Hurthle Cell Neoplasms: Filling in the Gaps Towards Clinical Application.
    Canberk S; Lima AR; Pinto M; Soares P; Máximo V
    Front Endocrinol (Lausanne); 2021; 12():674666. PubMed ID: 34108939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the cancer epigenome for therapy.
    Jones PA; Issa JP; Baylin S
    Nat Rev Genet; 2016 Sep; 17(10):630-41. PubMed ID: 27629931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.